This Week in Startups
This Week in Startups
Jason Calacanis
Why this longevity startup raised in Japan, not Silicon Valley | TWiST Tokyo | E2315
1 hour 12 minutes Posted Jul 22, 2026 at 8:48 pm.
Founder University is back in Japan!
What Ekei Labs does
Why Japan is a longevity hub
The AI biological moat
Sentry Your team should be focused on shipping features — not chasing down bugs. New users can get $240 in free credits when they go to https://sentry.io/twist and use the code TWIST
Right to try and the ethics of experimental therapies
Agree.com Stop chasing invoices and automate your entire contract-to-cash stack. Go to https://agree.com and tell them Jason sent you to get 50% off for life!
Japan's fast-track regenerative medicine law
Raising in Japan vs. the US
Northwest Registered Agent Get more when you start your business with Northwest. In 10 clicks and 10 minutes, you can form your company and walk away with a real business identity — Learn more at https://northwestregisteredagent.com/twist
Why Ekei killed a profitable service to focus
Have Blue Zones been debunked?
How socialization may extend lifespan
Founder Q&A: Booked vs. forecast revenue
Amazon's "bar raiser" framework
Social robots and loneliness
Jason on health and hustle culture
0:00
1:12:24
Download MP3
Show notes
This Week In Startups is made possible by:
Sentry https://sentry.io/twist
Agree https://agree.com
Northwest Registered Agent https://northwestregisteredagent.com/twist
Today's show:
French ex-martial artist Bilal Kharouni is building his longevity startup from Okinawa, one of the world's "blue zones." (These are regions with the most people living long, healthy lives.) In this TWiST taping from Founder University in Tokyo, Jason investigates why a $200K raise in Japan can out-build a $2M raise in San Francisco, and why the best moat for biological AI isn't the model; it's the data no one else has.
Plus a tactical and practical discussion of product market fit, why Ekei killed a growing side business to maintain focus, Japan's fast-track for regenerative medicine, and hitting the upper limits for consumer longevity gadgets. Plus a live Q&A with Founder U attendees.
Guest
Bilal Kharouni on LinkedIn: https://www.linkedin.com/in/bilal-kharouni/
Ekei Labs: https://www.ekeilabs.com/
Relevant Links
Okinawa Institute of Science and Tech (OIST): ****https://www.oist.jp/
Life Biosciences: https://www.lifebiosciences.com/
NewLimit: https://www.newlimit.com/
Centivax: https://www.centivax.com/
Medical Daily: "First Human Trial to Reverse Aging Gets FDA Clearance": https://www.medicaldaily.com/first-human-trial-reverse-aging-just-got-fda-clearance-what-epigenetic-reprogramming-actually-476076
Tim Friede snake venom article from Science: https://www.science.org/content/article/he-injected-himself-venom-decades-can-his-antibodies-help-snakebite-victims
Micro1: https://www.micro1.ai/
Whoop: https://www.whoop.com/
Station F Paris startup campus: https://stationf.co/
Japan Times: "PM Takaichi sleeps only 2-4 hours a night": https://www.japantimes.co.jp/news/2025/11/14/japan/politics/takaichi-sleep-overwork/
FDLI: "Japan's Regenerative Medicine Regulatory Pathways": https://www.fdli.org/2019/02/global-focus-japans-regenerative-medicine-regulatory-pathways-encouraging-innovation-and-patient-access/
FDA: "Right to Try": https://www.fda.gov/patients/learn-about-expanded-access-and-other-treatment-options/right-try
STAT News: "Are Blue Zones Real?": https://www.statnews.com/2026/05/04/are-blue-zones-real-new-scrutiny-longevity-hot-spots/
Timestamps:
Subscribe to the TWiST500 newsletter: https://ticker.thisweekinstartups.com
Check out the TWIST500: https://www.twist500.com
Subscribe to This Week in Startups on Apple: https://rb.gy/v19fcp
Follow Lon:
X: https://x.com/lons
Follow Alex:
X: https://x.com/alex
LinkedIn: ⁠https://www.linkedin.com/in/alexwilhelm
Follow Jason:
X: https://twitter.com/Jason
LinkedIn: https://www.linkedin.com/in/jasoncalacanis
Check out all our partner offers: https://partners.launch.co/
Great TWIST interviews: Will Guidara, Eoghan McCabe, Steve Huffman, Brian Chesky, Bob Moesta, Aaron Levie, Sophia Amoruso, Reid Hoffman, Frank Slootman, Billy McFarland
Check out Jason's suite of newsletters: https://substack.com/@calacanis
Follow TWiST:
Twitter: https://twitter.com/TWiStartups
YouTube: https://www.youtube.com/thisweekin
Instagram: https://www.instagram.com/thisweekinstartups
TikTok: https://www.tiktok.com/@thisweekinstartups
Substack: https://twistartups.substack.com